INS and type 1 diabetes mellitus: Specifically, autoantibodies to β-cell antigens, such as glutamic acid decarboxylase, insulin, or protein tyrosine phosphatase, which can be present in T1D patients (30, 31), have been detected in 0.8%-8.5% of CF patients (28, 29, 32).